SRTS
Sensus Healthcare, Inc.
Sensus Healthcare, Inc. insider trading
Insiders at Sensus Healthcare, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Sachetta Eric (Director) buying $129K of SRTS, filed Aug 31, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $225.6K
- Sold
- —
- Insiders
- 1
- Latest trade
- Aug 28, 2026
From SEC filings · last 30 days
Recent SRTS insider transactions
SEC Form 4 data, Q3 2024 to Q2 2026
SRTS insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded SRTS on the open market: 13 purchases worth $177.8K and 0 sales. In the last four quarters alone: 11 purchases ($168.8K) and 0 sales, by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$5K1 buy | — | |
| Q1 2026 | +$7.6K1 buy | — | |
| Q4 2025 | +$152.8K8 buys | — | |
| Q3 2025 | +$3.4K1 buy | — | |
| Q2 2025 | — | — | |
| Q1 2025 | +$8.9K2 buys | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$100.8K of SRTS by Sardano Joseph C (Chief Executive Officer · Director) on Nov 18, 2025.
Open-market transactions through Jun 30, 2026most recent first
Sachetta Eric
Director
+$5K
May 12, 2026
1,500 sh · $3.34
Sachetta Eric
Director
+$7.6K
Feb 24, 2026
2,000 sh · $3.81
Sachetta Eric
Director
+$27.5K
Nov 21, 2025
7,000 sh · $3.93
Sardano Joseph C
Chief Executive Officer · Director
+$100.8K
Nov 18, 2025
25,000 sh · $4.03
Sardano Michael
President And General Counsel · Director
+$3.8K
Nov 18, 2025
1,000 sh · $3.80
Sachetta Eric
Director
+$11.3K
Nov 13, 2025
2,500 sh · $4.50
Sardano Michael
President And General Counsel · Director
+$4.3K
Nov 11, 2025
1,000 sh · $4.26
Sardano Michael
President And General Counsel · Director
+$3.3K
Nov 11, 2025
766 sh · $4.27
Sardano Michael
President And General Counsel · Director
+$1K
Nov 11, 2025
234 sh · $4.34
Sardano Michael
President And General Counsel · Director
+$992
Nov 11, 2025
234 sh · $4.24
Sardano Michael
President And General Counsel · Director
+$3.4K
Aug 13, 2025
1,000 sh · $3.37
Sardano Michael
President And General Counsel · Director
+$6K
Feb 10, 2025
1,000 sh · $5.95
Rampolla Javier
Chief Financial Officer
+$3K
Feb 10, 2025
501 sh · $5.95
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 12, 2026 | Sachetta EricDirector | 1,500 | $3.34 | +$5K |
| Feb 24, 2026 | Sachetta EricDirector | 2,000 | $3.81 | +$7.6K |
| Nov 21, 2025 | Sachetta EricDirector | 7,000 | $3.93 | +$27.5K |
| Nov 18, 2025 | Sardano Joseph CChief Executive Officer · Director | 25,000 | $4.03 | +$100.8K |
| Nov 18, 2025 | Sardano MichaelPresident And General Counsel · Director | 1,000 | $3.80 | +$3.8K |
| Nov 13, 2025 | Sachetta EricDirector | 2,500 | $4.50 | +$11.3K |
| Nov 11, 2025 | Sardano MichaelPresident And General Counsel · Director | 1,000 | $4.26 | +$4.3K |
| Nov 11, 2025 | Sardano MichaelPresident And General Counsel · Director | 766 | $4.27 | +$3.3K |
| Nov 11, 2025 | Sardano MichaelPresident And General Counsel · Director | 234 | $4.34 | +$1K |
| Nov 11, 2025 | Sardano MichaelPresident And General Counsel · Director | 234 | $4.24 | +$992 |
| Aug 13, 2025 | Sardano MichaelPresident And General Counsel · Director | 1,000 | $3.37 | +$3.4K |
| Feb 10, 2025 | Sardano MichaelPresident And General Counsel · Director | 1,000 | $5.95 | +$6K |
| Feb 10, 2025 | Rampolla JavierChief Financial Officer | 501 | $5.95 | +$3K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check SRTS — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Sensus Healthcare, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are SRTS insiders buying or selling?
- Between Aug 31, 2026 and Aug 28, 2026, 1 Sensus Healthcare, Inc. insider made 2 open-market purchases worth $225.6K and no sales, a net purchase of $225.6K.
- How much SRTS stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 4 Sensus Healthcare, Inc. insiders made 13 open-market purchases worth $177.8K and no sales. In the four quarters to Jun 30, 2026: 11 purchases ($168.8K) and no sales. The largest purchase was Sardano Joseph C buying $100.8K on Nov 18, 2025.
- What was the largest recent SRTS insider trade?
- Sachetta Eric (Director) bought $129K of SRTS stock on Aug 28, 2026 at about $3.44 a share.
- When did an insider last buy SRTS shares?
- The most recent open-market purchase on file is Sachetta Eric (Director) buying $96.6K on Aug 31, 2026. The largest purchase in the period was $129K by Sachetta Eric.
- Where does SRTS insider trading data come from?
- From the Form 4 filings Sensus Healthcare, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in SRTS and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.